Innate Pharma Announces Closing of Global Offering

NEXT STORY
NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Vaccine V920 (ERVEBO®)
PREV STORY
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Harpoon Therapeutics Appoints Experienced Biotech Leader Alan Colowick, M.D., to Board of Directors

author_avatar
NASDAQ Market News

Checkpoint Therapeutics Announces Formation of Scientific Advisory Board

author_avatar
NASDAQ Market News

eFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News